Artur Zembowicz1, Richard A Scolyer. 1. Department of Pathology, Lahey Clinic, Burlington, Massachusetts, USA. dr.z@DermatopathologyConsultations.com
Abstract
CONTEXT: Until recently, the prevailing paradigm in classification and clinical management of melanocytic proliferations mandated dichotomous classification of all melanocytic lesions as either entirely benign (nevus) or entirely malignant (melanoma). However, some diagnostically challenging lesions cannot be unequivocally classified as nevus or melanoma by histologic evaluation of the primary tumor. Such lesions have been referred to as borderline or melanocytic tumors of uncertain malignant potential. OBJECTIVE: To review and update the problem of diagnostically difficult melanocytic proliferations and recent concepts regarding borderline melanocytic tumors. DATA SOURCES: Published literature and personal experience of the authors. CONCLUSIONS: Preliminary evidence indicates that it may be appropriate to expand the classification scheme of melanocytic neoplasms to include a third diagnostic category of melanocytic lesions of intermediate malignant potential that are capable of metastasis to regional lymph nodes but have limited potential for distant spread. We propose the term melanocytoma for this group of lesions. We believe that a nevus/melanocytoma/melanoma paradigm may provide a useful intellectual framework to understand, research, and clinically manage borderline melanocytic tumors.
CONTEXT: Until recently, the prevailing paradigm in classification and clinical management of melanocytic proliferations mandated dichotomous classification of all melanocytic lesions as either entirely benign (nevus) or entirely malignant (melanoma). However, some diagnostically challenging lesions cannot be unequivocally classified as nevus or melanoma by histologic evaluation of the primary tumor. Such lesions have been referred to as borderline or melanocytic tumors of uncertain malignant potential. OBJECTIVE: To review and update the problem of diagnostically difficult melanocytic proliferations and recent concepts regarding borderline melanocytic tumors. DATA SOURCES: Published literature and personal experience of the authors. CONCLUSIONS: Preliminary evidence indicates that it may be appropriate to expand the classification scheme of melanocytic neoplasms to include a third diagnostic category of melanocytic lesions of intermediate malignant potential that are capable of metastasis to regional lymph nodes but have limited potential for distant spread. We propose the term melanocytoma for this group of lesions. We believe that a nevus/melanocytoma/melanoma paradigm may provide a useful intellectual framework to understand, research, and clinically manage borderline melanocytic tumors.
Authors: Kachiu C Lee; Sue Peacock; Martin A Weinstock; Ge Alice Zhao; Stevan R Knezevich; David E Elder; Raymond L Barnhill; Michael W Piepkorn; Lisa M Reisch; Patricia A Carney; Tracy Onega; Jason P Lott; Joann G Elmore Journal: J Am Acad Dermatol Date: 2016-09-28 Impact factor: 11.527
Authors: Erik R Johnson; Michael E Korchak; Todd A Goodglick; Jasbir S Johal; Craig R Dufresne; Sina J Sabet Journal: Ocul Oncol Pathol Date: 2017-07-26
Authors: Richard A Scolyer; Meagan J Judge; Alan Evans; David P Frishberg; Victor G Prieto; John F Thompson; Martin J Trotter; Maureen Y Walsh; Noreen M G Walsh; David W Ellis Journal: Am J Surg Pathol Date: 2013-12 Impact factor: 6.394
Authors: Allison R Larson; Karen A Dresser; Qian Zhan; Cecilia Lezcano; Bruce A Woda; Benafsha Yosufi; John F Thompson; Richard A Scolyer; Martin C Mihm; Yujiang G Shi; George F Murphy; Christine Guo Lian Journal: Mod Pathol Date: 2014-01-03 Impact factor: 7.842
Authors: Rami N Al-Rohil; Jessica L Moore; Nathan Heath Patterson; Sarah Nicholson; Nico Verbeeck; Marc Claesen; Jameelah Z Muhammad; Richard M Caprioli; Jeremy L Norris; Sara Kantrow; Margaret Compton; Jason Robbins; Ahmed K Alomari Journal: J Cutan Pathol Date: 2021-07-02 Impact factor: 1.587